Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

33.95
Delayed Data
As of May 22
 +0.05 / +0.15%
Today’s Change
25.55
Today|||52-Week Range
35.04
+24.27%
Year-to-Date
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab
May 22 / Zacks.com - Paid Partner Content
What's in Store for Merck KGaA (MKGAF) in Q1 Earnings?
May 12 / Zacks.com - Paid Partner Content
Clovis' (CLVS) PARP Inhibtor Shows Promise, Risks Remain
May 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study
May 12 / Zacks.com - Paid Partner Content
Endocyte (ECYT) Focused on Two Lead Pipeline Candidates
May 18 / Zacks.com - Paid Partner Content
Trump does a China deal; Laptop ban; Retail pain
May 12 / CNNMoney.com
AstraZeneca Imfinzi Positive in Phase III Lung Cancer Study
May 15 / Zacks.com - Paid Partner Content
Nektar Therapeutics (NKTR) Loss Wider Than Expected in Q1
May 11 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Shows Strength: Stock Moves 9.2% Higher
May 15 / Zacks.com - Paid Partner Content
Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss
May 09 / Zacks.com - Paid Partner Content